Rhinatrema bivittatum chromosome 18, aRhiBiv1.1, whole genome shotgun sequence.
Rhinatrema bivittatum (two-lined caecilian)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia; Gymnophiona; Rhinatrematidae; Rhinatrema.
REFSEQ INFORMATION: The reference sequence is identical to\nLR584404.1.\nAssembly name: aRhiBiv1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the SC on 2019/06/02. The\noriginal whole-genome shotgun project has the accession\nCAAJIB000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Rhinatrema bivittatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.2\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dedicator of cytokinesis protein 2-like
heterogeneous nuclear ribonucleoprotein H1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H1, transcript variant X2
heterogeneous nuclear ribonucleoprotein H isoform X1
heterogeneous nuclear ribonucleoprotein H isoform X2
RUN and FYVE domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RUN and FYVE domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
RUN and FYVE domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1 isoform X2
RUN and FYVE domain-containing protein 1 isoform X1
RUN and FYVE domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
heparin binding EGF like growth factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
heparin binding EGF like growth factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
proheparin-binding EGF-like growth factor
prefoldin subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
prefoldin subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
prefoldin subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
poly(A) binding protein interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
poly(A) binding protein interacting protein 2, transcript variant X3
poly(A) binding protein interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
polyadenylate-binding protein-interacting protein 2 isoform X2
polyadenylate-binding protein-interacting protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 23 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 23 member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 23 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 23 member 1 isoform X1
solute carrier family 23 member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X4
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X5
endothelial cell-specific chemotaxis regulator isoform X3
endothelial cell-specific chemotaxis regulator isoform X2
endothelial cell-specific chemotaxis regulator isoform X1
endothelial cell-specific chemotaxis regulator isoform X4
transmembrane protein 173, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 173, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
stimulator of interferon genes protein isoform X1
stimulator of interferon genes protein isoform X2
transmembrane protein 173, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 173, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 173, transcript variant X3
ubiquitin conjugating enzyme E2 D2, transcript variant X3
ubiquitin conjugating enzyme E2 D2, transcript variant X4
ubiquitin conjugating enzyme E2 D2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 D2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 D2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 D2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 D2 isoform X1
ubiquitin-conjugating enzyme E2 D2 isoform X2
ubiquitin-conjugating enzyme E2 D2 isoform X3
ubiquitin-conjugating enzyme E2 D2 isoform X4
ubiquitin-conjugating enzyme E2 D2 isoform X5
ubiquitin-conjugating enzyme E2 D2 isoform X6
CXXC finger protein 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X11
CXXC finger protein 5, transcript variant X13
CXXC finger protein 5, transcript variant X12
CXXC finger protein 5, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X2
CXXC finger protein 5, transcript variant X7
CXXC finger protein 5, transcript variant X6
CXXC finger protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X4
CXXC finger protein 5, transcript variant X1
CXXC finger protein 5, transcript variant X10
CXXC finger protein 5, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
CXXC-type zinc finger protein 5 isoform X4
CXXC-type zinc finger protein 5 isoform X5
CXXC-type zinc finger protein 5 isoform X2
CXXC-type zinc finger protein 5 isoform X3
CXXC-type zinc finger protein 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transcriptional activator protein Pur-alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lymphocyte cytosolic protein 2, transcript variant X2
lymphocyte cytosolic protein 2, transcript variant X1
lymphocyte cytosolic protein 2 isoform X2
lymphocyte cytosolic protein 2 isoform X1
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X3
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
potassium calcium-activated channel subfamily M regulatory beta subunit 1, transcript variant X1
calcium-activated potassium channel subunit beta-1
potassium voltage-gated channel interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X2
gamma-aminobutyric acid type A receptor pi subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
gamma-aminobutyric acid receptor subunit pi
kazal-type serine protease inhibitor domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC115079888, transcript variant X1
uncharacterized LOC115079888, transcript variant X2
RAN binding protein 17, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RAN binding protein 17, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RAN binding protein 17, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC115080086, transcript variant X2
uncharacterized LOC115080086, transcript variant X3
uncharacterized LOC115080086, transcript variant X1
F-box and WD repeat domain containing 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
F-box and WD repeat domain containing 11, transcript variant X2
F-box/WD repeat-containing protein 11 isoform X2
F-box/WD repeat-containing protein 11 isoform X1
eukaryotic translation termination factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
eukaryotic translation termination factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
eukaryotic translation termination factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
eukaryotic translation termination factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
eukaryotic peptide chain release factor subunit 1 isoform X1
eukaryotic peptide chain release factor subunit 1 isoform X2
heat shock protein family A (Hsp70) member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: stress-70 protein, mitochondrial
COORDINATES: nucleotide motif:Rfam:12.0:RF00154
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine rich repeat transmembrane neuronal 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat transmembrane neuronal protein 2
SIL1 nucleotide exchange factor, transcript variant X2
SIL1 nucleotide exchange factor, transcript variant X1
nucleotide exchange factor SIL1 isoform X2
nucleotide exchange factor SIL1 isoform X1
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pantothenate kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pantothenate kinase 3, transcript variant X3
pantothenate kinase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X1
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
rho GTPase-activating protein 7-like isoform X3
rho GTPase-activating protein 7-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
rho GTPase-activating protein 7-like isoform X2
rho GTPase-activating protein 7-like, transcript variant X7
rho GTPase-activating protein 7-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
methionine adenosyltransferase 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
methionine adenosyltransferase 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
methionine adenosyltransferase 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
methionine adenosyltransferase 2 subunit beta isoform X2
methionine adenosyltransferase 2 subunit beta isoform X3
methionine adenosyltransferase 2 subunit beta isoform X1
hyaluronan mediated motility receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hyaluronan mediated motility receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
hyaluronan mediated motility receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
hyaluronan mediated motility receptor isoform X2
hyaluronan mediated motility receptor isoform X1
hyaluronan mediated motility receptor isoform X3
NudC domain containing 2, transcript variant X1
NudC domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
nudC domain-containing protein 2 isoform X2
nudC domain-containing protein 2 isoform X1
equilibrative nucleoside transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor gamma2 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit gamma-2
gamma-aminobutyric acid type A receptor alpha1 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit alpha-1
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X4
gamma-aminobutyric acid receptor subunit beta-2 isoform X1
gamma-aminobutyric acid receptor subunit beta-2 isoform X3
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-2 isoform X2
uncharacterized LOC115079919, transcript variant X2
uncharacterized LOC115079919, transcript variant X1
ATPase phospholipid transporting 10B (putative), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase phospholipid transporting 10B (putative), transcript variant X8
ATPase phospholipid transporting 10B (putative), transcript variant X6
ATPase phospholipid transporting 10B (putative), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ATPase phospholipid transporting 10B (putative), transcript variant X1
ATPase phospholipid transporting 10B (putative), transcript variant X5
ATPase phospholipid transporting 10B (putative), transcript variant X7
ATPase phospholipid transporting 10B (putative), transcript variant X9
ATPase phospholipid transporting 10B (putative), transcript variant X2
probable phospholipid-transporting ATPase VB isoform X1
ATPase phospholipid transporting 10B (putative), transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
probable phospholipid-transporting ATPase VB isoform X2
ATPase phospholipid transporting 10B (putative), transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
probable phospholipid-transporting ATPase VB isoform X3
natural cytotoxicity triggering receptor 3
PTTG1 regulator of sister chromatid separation, securin
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
C1q and TNF related 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
C1q and TNF related 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
amyloid beta precursor protein binding family B member 3
amyloid-beta A4 precursor protein-binding family B member 3
SLC35A4 upstream open reading frame protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
kinesin-like protein klp-20, transcript variant X3
kinesin-like protein klp-20, transcript variant X1
kinesin-like protein klp-20, transcript variant X2
uncharacterized protein LOC115079829 isoform X3
toll-like receptor 2, transcript variant X1
toll-like receptor 2, transcript variant X2
toll-like receptor 2, transcript variant X3
transmembrane and coiled-coil domains 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X2
transmembrane and coiled-coil domain-containing protein 6 isoform X1
transmembrane and coiled-coil domain-containing protein 6 isoform X2
NADH:ubiquinone oxidoreductase subunit A2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
WD repeat domain 55, transcript variant X6
WD repeat domain 55, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
WD repeat domain 55, transcript variant X7
WD repeat domain 55, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
WD repeat domain 55, transcript variant X5
WD repeat domain 55, transcript variant X1
WD repeat-containing protein 55 isoform X1
WD repeat-containing protein 55 isoform X4
WD repeat-containing protein 55 isoform X6
WD repeat-containing protein 55 isoform X7
WD repeat-containing protein 55 isoform X2
WD repeat-containing protein 55 isoform X5
WD repeat domain 55, transcript variant X3
WD repeat-containing protein 55 isoform X3
DND microRNA-mediated repression inhibitor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X1
histidine--tRNA ligase, cytoplasmic-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like isoform X2
histidine--tRNA ligase, cytoplasmic-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
zinc finger matrin-type 2, transcript variant X1
zinc finger matrin-type protein 2 isoform X1
zinc finger matrin-type 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger matrin-type protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 50% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 4% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC115080059
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 183 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 275 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 135 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 161 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 131 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 102 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 200 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 166 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 123 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 151 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 125 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 4 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-B1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 112 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 157 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 116 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 105 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protocadherin gamma-A4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 130 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 122 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
diaphanous related formin 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
diaphanous related formin 1, transcript variant X2
diaphanous related formin 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
diaphanous related formin 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
histone deacetylase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histone deacetylase 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
histone deacetylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
FCH and double SH3 domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
FCH and double SH3 domains 1, transcript variant X2
F-BAR and double SH3 domains protein 1 isoform X1
F-BAR and double SH3 domains protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X5
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X4
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X9
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X7
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X3
START domain-containing protein 10-like, transcript variant X1
START domain-containing protein 10-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
START domain-containing protein 10-like, transcript variant X3
START domain-containing protein 10-like isoform X2
START domain-containing protein 10-like isoform X1
START domain-containing protein 10-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mastermind like transcriptional coactivator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
leukotriene C4 synthase, transcript variant X2
similar to RNA sequence (same species):INSD:GFOG01028875.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 145 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 145 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
leukotriene C4 synthase, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 145 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TBC1 domain family member 9B, transcript variant X2
TBC1 domain family member 9B, transcript variant X1
ring finger protein 130, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF130 isoform X2
ring finger protein 130, transcript variant X1
E3 ubiquitin-protein ligase RNF130 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vascular endothelial growth factor receptor 3
zinc-binding protein A33-like, transcript variant X1
zinc-binding protein A33-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
zinc-binding protein A33-like, transcript variant X2
zinc-binding protein A33-like isoform X1
zinc-binding protein A33-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
HMG-box containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
HMG-box containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
HMG-box containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
HMG domain-containing protein 3 isoform X1
HMG domain-containing protein 3 isoform X3
HMG domain-containing protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
macrophage colony-stimulating factor 1 receptor
platelet derived growth factor receptor beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
platelet derived growth factor receptor beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
platelet-derived growth factor receptor beta isoform X1
platelet-derived growth factor receptor beta isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: homeobox protein CDX-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
calcium/calmodulin dependent protein kinase II alpha
calcium/calmodulin-dependent protein kinase type II subunit alpha
nucleolar and coiled-body phosphoprotein 1-like, transcript variant X1
nucleolar and coiled-body phosphoprotein 1-like, transcript variant X2
nucleolar and coiled-body phosphoprotein 1-like isoform X1
nucleolar and coiled-body phosphoprotein 1-like isoform X2
HLA class II histocompatibility antigen gamma chain
ribosomal protein S14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal protein S14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal protein S14, transcript variant X1
ribosomal protein S14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
N-deacetylase and N-sulfotransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
N-deacetylase and N-sulfotransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RNA binding motif protein 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
RNA binding motif protein 22, transcript variant X2
pre-mRNA-splicing factor RBM22 isoform X1
pre-mRNA-splicing factor RBM22 isoform X2
dynactin subunit 4, transcript variant X2
dynactin subunit 4, transcript variant X1
protein NDNF-like, transcript variant X2
protein NDNF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zona pellucida sperm-binding protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
platelet-derived growth factor receptor-like protein, transcript variant X2
platelet-derived growth factor receptor-like protein isoform X2
platelet-derived growth factor receptor-like protein, transcript variant X3
platelet-derived growth factor receptor-like protein isoform X3
platelet-derived growth factor receptor-like protein, transcript variant X1
platelet-derived growth factor receptor-like protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 69
ganglioside GM2 activator-like, transcript variant X2
ganglioside GM2 activator-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like, transcript variant X1
proton-coupled amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like, transcript variant X4
proton-coupled amino acid transporter 1-like isoform X1
proton-coupled amino acid transporter 1-like, transcript variant X5
proton-coupled amino acid transporter 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
secreted protein acidic and cysteine rich
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
antioxidant 1 copper chaperone, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
antioxidant 1 copper chaperone, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
copper transport protein ATOX1 isoform X2
copper transport protein ATOX1 isoform X1
G3BP stress granule assembly factor 1, transcript variant X1
G3BP stress granule assembly factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ras GTPase-activating protein-binding protein 1 isoform X1
G3BP stress granule assembly factor 1, transcript variant X3
ras GTPase-activating protein-binding protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X1
LON peptidase N-terminal domain and RING finger protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
LON peptidase N-terminal domain and RING finger protein 1-like isoform X1
LON peptidase N-terminal domain and RING finger protein 1-like, transcript variant X2
LON peptidase N-terminal domain and RING finger protein 1-like isoform X2
family with sequence similarity 114 member A2, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
polypeptide N-acetylgalactosaminyltransferase 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
histone deacetylase complex subunit SAP30L
heart and neural crest derivatives expressed 1
heart- and neural crest derivatives-expressed protein 1
La ribonucleoprotein domain family member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
La ribonucleoprotein domain family member 1, transcript variant X2
La ribonucleoprotein domain family member 1, transcript variant X3
La ribonucleoprotein domain family member 1, transcript variant X4
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain-containing protein 2
CCR4-NOT transcription complex subunit 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
gem nuclear organelle associated protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X1
mitochondrial ribosomal protein L22, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
39S ribosomal protein L22, mitochondrial isoform X1
39S ribosomal protein L22, mitochondrial isoform X2
39S ribosomal protein L22, mitochondrial isoform X3
sarcoglycan delta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sarcoglycan delta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sarcoglycan delta, transcript variant X1
sarcoglycan delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sarcoglycan delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sarcoglycan delta, transcript variant X5
sarcoglycan delta, transcript variant X3
sarcoglycan delta, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
T-cell immunoglobulin and mucin domain-containing protein 4-like
hepatitis A virus cellular receptor 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
hepatitis A virus cellular receptor 1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
hepatitis A virus cellular receptor 1 homolog isoform X2
hepatitis A virus cellular receptor 1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 7
cytoplasmic FMR1 interacting protein 2, transcript variant X3
cytoplasmic FMR1 interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic FMR1-interacting protein 2 isoform X1
cytoplasmic FMR1-interacting protein 2 isoform X2
cytoplasmic FMR1 interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic FMR1-interacting protein 2 isoform X3
fibronectin type III domain containing 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
fibronectin type III domain-containing protein 9
NIPA like domain containing 4, transcript variant X1
NIPA like domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
NIPA like domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19
SRY-box transcription factor 30, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SRY-box transcription factor 30, transcript variant X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tRNA-histidine guanylyltransferase 1 like, transcript variant X2
tRNA-histidine guanylyltransferase 1 like, transcript variant X4
tRNA-histidine guanylyltransferase 1 like, transcript variant X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tRNA-histidine guanylyltransferase 1 like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tRNA-histidine guanylyltransferase 1 like, transcript variant X6
tRNA-histidine guanylyltransferase 1 like, transcript variant X7
tRNA-histidine guanylyltransferase 1 like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
probable tRNA(His) guanylyltransferase isoform X2
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X3
probable tRNA(His) guanylyltransferase isoform X4
probable tRNA(His) guanylyltransferase isoform X5
LSM11, U7 small nuclear RNA associated, transcript variant X2
LSM11, U7 small nuclear RNA associated, transcript variant X1
U7 snRNA-associated Sm-like protein LSm11 isoform X2
U7 snRNA-associated Sm-like protein LSm11 isoform X1
clathrin interactor 1, transcript variant X1
clathrin interactor 1, transcript variant X2
EBF transcription factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
EBF transcription factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
EBF transcription factor 1, transcript variant X4
EBF transcription factor 1, transcript variant X1
EBF transcription factor 1, transcript variant X5
EBF transcription factor 1, transcript variant X2
uncharacterized LOC115079845, transcript variant X1
uncharacterized LOC115079845, transcript variant X2
uncharacterized LOC115079845, transcript variant X3
ring finger protein 145, transcript variant X2
ring finger protein 145, transcript variant X1
ring finger protein 145, transcript variant X4
ring finger protein 145, transcript variant X3
ring finger protein 145, transcript variant X6
ring finger protein 145, transcript variant X5
ubiquitin like domain containing CTD phosphatase 1, transcript variant X1
ubiquitin like domain containing CTD phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ubiquitin-like domain-containing CTD phosphatase 1
matrix metalloproteinase-21-like, transcript variant X5
matrix metalloproteinase-21-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
matrix metalloproteinase-21-like, transcript variant X4
matrix metalloproteinase-21-like, transcript variant X7
matrix metalloproteinase-21-like, transcript variant X8
matrix metalloproteinase-21-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
matrix metalloproteinase-21-like, transcript variant X6
matrix metalloproteinase-21-like, transcript variant X3
matrix metalloproteinase-21-like isoform X2
matrix metalloproteinase-21-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X2
PWWP domain containing 2A, transcript variant X1
fatty acid binding protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
electrogenic sodium bicarbonate cotransporter 1-like isoform X1
electrogenic sodium bicarbonate cotransporter 1-like isoform X2
ankyrin repeat and KH domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1-like, transcript variant X3
ankyrin repeat and KH domain-containing protein 1-like, transcript variant X4
ankyrin repeat and KH domain-containing protein 1-like isoform X1
ankyrin repeat and KH domain-containing protein 1-like isoform X2
ankyrin repeat and KH domain-containing protein 1-like isoform X3
ankyrin repeat and KH domain-containing protein 1-like isoform X4
eukaryotic translation initiation factor 4E binding protein 3, transcript variant X1
eukaryotic translation initiation factor 4E binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-binding protein 3 isoform X1
eukaryotic translation initiation factor 4E-binding protein 3 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A disintegrin and metalloproteinase with thrombospondin motifs 2-like
uncharacterized LOC115079965, transcript variant X2
uncharacterized LOC115079965, transcript variant X3
uncharacterized LOC115079965, transcript variant X4
uncharacterized LOC115079965, transcript variant X7
uncharacterized LOC115079965, transcript variant X6
uncharacterized LOC115079965, transcript variant X1
uncharacterized protein LOC115079965 isoform X1
uncharacterized LOC115079965, transcript variant X5
uncharacterized protein LOC115079965 isoform X2
interleukin-8-like, transcript variant X2
interleukin-8-like, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6 isoform X2
CCR4-NOT transcription complex subunit 6 isoform X1
uncharacterized LOC115079757, transcript variant X1
uncharacterized LOC115079757, transcript variant X2
glutamine-fructose-6-phosphate transaminase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamine-fructose-6-phosphate transaminase 2, transcript variant X2
glutamine-fructose-6-phosphate transaminase 2, transcript variant X3
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X1
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X3
mitogen-activated protein kinase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X3
ras-GEF domain-containing family member 1C
CDC like kinase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
CDC like kinase 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dual specificity protein kinase CLK4 isoform X1
dual specificity protein kinase CLK4 isoform X2
CDC like kinase 4, transcript variant X3
dual specificity protein kinase CLK4 isoform X3
collagen type XXIII alpha 1 chain, transcript variant X3
collagen type XXIII alpha 1 chain, transcript variant X7
collagen type XXIII alpha 1 chain, transcript variant X1
collagen type XXIII alpha 1 chain, transcript variant X2
collagen type XXIII alpha 1 chain, transcript variant X8
collagen type XXIII alpha 1 chain, transcript variant X4
collagen type XXIII alpha 1 chain, transcript variant X6
collagen type XXIII alpha 1 chain, transcript variant X5
collagen type XXIII alpha 1 chain, transcript variant X9
collagen alpha-1(XXIII) chain isoform X1
collagen alpha-1(XXIII) chain isoform X6
collagen alpha-1(XXIII) chain isoform X3
collagen alpha-1(XXIII) chain isoform X7
collagen alpha-1(XXIII) chain isoform X5
collagen alpha-1(XXIII) chain isoform X2
collagen alpha-1(XXIII) chain isoform X8
collagen alpha-1(XXIII) chain isoform X4
collagen alpha-1(XXIII) chain isoform X9
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X1
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X2
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X1
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X6
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X4
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X7
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X8
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X1
heterogeneous nuclear ribonucleoprotein A/B isoform X2
heterogeneous nuclear ribonucleoprotein A/B isoform X1
NME/NM23 family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
NME/NM23 family member 5, transcript variant X2
NME/NM23 family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 13 member B, transcript variant X1
family with sequence similarity 13 member B, transcript variant X2
family with sequence similarity 13 member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
family with sequence similarity 13 member B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
family with sequence similarity 13 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X2
polycystic kidney disease 2-like 2 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC115080081, transcript variant X1
uncharacterized LOC115080081, transcript variant X2
heterogeneous nuclear ribonucleoprotein A0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 3, transcript variant X3
kelch like family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kelch like family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
kelch like family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch like family member 3, transcript variant X4
kelch like family member 3, transcript variant X6
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
transient receptor potential cation channel subfamily C member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
short transient receptor potential channel 7
SMAD family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
SMAD family member 5, transcript variant X4
mothers against decapentaplegic homolog 5 isoform X3
SMAD family member 5, transcript variant X3
mothers against decapentaplegic homolog 5 isoform X2
SMAD family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
mothers against decapentaplegic homolog 5 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transforming growth factor-beta-induced protein ig-h3
F-box/LRR-repeat protein 21-like, transcript variant X2
F-box/LRR-repeat protein 21-like, transcript variant X3
F-box/LRR-repeat protein 21-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box/LRR-repeat protein 21-like, transcript variant X5
F-box/LRR-repeat protein 21-like, transcript variant X6
F-box/LRR-repeat protein 21-like, transcript variant X4
F-box/LRR-repeat protein 21-like, transcript variant X1
F-box/LRR-repeat protein 21-like isoform X3
F-box/LRR-repeat protein 21-like isoform X2
F-box/LRR-repeat protein 21-like isoform X1
F-box/LRR-repeat protein 21-like isoform X4
solute carrier family 25 member 48, transcript variant X5
solute carrier family 25 member 48, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 25 member 48, transcript variant X3
solute carrier family 25 member 48, transcript variant X1
solute carrier family 25 member 48, transcript variant X4
solute carrier family 25 member 48 isoform X3
solute carrier family 25 member 48 isoform X2
solute carrier family 25 member 48 isoform X1
solute carrier family 25 member 48 isoform X4
uncharacterized LOC115079955, transcript variant X2
uncharacterized LOC115079955, transcript variant X1
core histone macro-H2A.1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC115079992, transcript variant X1
uncharacterized LOC115079992, transcript variant X2
paired like homeodomain 1, transcript variant X1
paired like homeodomain 1, transcript variant X2
paired like homeodomain 1, transcript variant X3
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X2
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X3
uncharacterized protein LOC115079631 isoform X2
pterin-4-alpha-carbinolamine dehydratase 2-like isoform X3
pterin-4-alpha-carbinolamine dehydratase 2-like, transcript variant X1
thioredoxin domain-containing protein 15-like isoform X1
chromosome 18 C5orf24 homolog, transcript variant X2
chromosome 18 C5orf24 homolog, transcript variant X3
chromosome 18 C5orf24 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
UPF0461 protein C5orf24 homolog isoform X2
UPF0461 protein C5orf24 homolog isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LOW QUALITY PROTEIN: probable ATP-dependent RNA helicase DDX46
calcium modulating ligand, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium modulating ligand, transcript variant X2
calcium signal-modulating cyclophilin ligand isoform X2
calcium signal-modulating cyclophilin ligand isoform X1
secretion associated Ras related GTPase 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SEC24 homolog A, COPII coat complex component, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SEC24 homolog A, COPII coat complex component, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
SEC24 homolog A, COPII coat complex component, transcript variant X1
SEC24 homolog A, COPII coat complex component, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein transport protein Sec24A isoform X2
protein transport protein Sec24A isoform X1
secretion associated Ras related GTPase 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
jade family PHD finger 2, transcript variant X2
jade family PHD finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
E3 ubiquitin-protein ligase Jade-2 isoform X2
E3 ubiquitin-protein ligase Jade-2 isoform X1
CDKN2A interacting protein N-terminal like, transcript variant X2
CDKN2A interacting protein N-terminal like, transcript variant X1
CDKN2AIP N-terminal-like protein isoform X1
CDKN2AIP N-terminal-like protein isoform X2
ubiquitin conjugating enzyme E2 B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 B isoform X1
ubiquitin-conjugating enzyme E2 B isoform X2
ubiquitin-conjugating enzyme E2 B isoform X3
cyclin dependent kinase like 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cyclin dependent kinase like 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin dependent kinase like 3, transcript variant X4
cyclin dependent kinase like 3, transcript variant X3
cyclin dependent kinase like 3, transcript variant X1
cyclin dependent kinase like 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cyclin dependent kinase like 3, transcript variant X7
cyclin-dependent kinase-like 3 isoform X1
cyclin-dependent kinase-like 3 isoform X2
cyclin-dependent kinase-like 3 isoform X3
protein phosphatase 2 catalytic subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 73 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
S-phase kinase associated protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
S-phase kinase associated protein 1, transcript variant X2
transcription factor 7, transcript variant X8
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X7
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X9
transcription factor 7, transcript variant X5
transcription factor 7, transcript variant X6
transcription factor 7, transcript variant X1
transcription factor 7, transcript variant X11
transcription factor 7, transcript variant X4
transcription factor 7, transcript variant X10
transcription factor 7, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
voltage-dependent anion-selective channel protein 1
chromosome 18 C5orf15 homolog, transcript variant X1
chromosome 18 C5orf15 homolog, transcript variant X2
keratinocyte-associated transmembrane protein 2 isoform X1
keratinocyte-associated transmembrane protein 2 isoform X2
follistatin like 4, transcript variant X1
follistatin-related protein 4 isoform X1
follistatin like 4, transcript variant X2
follistatin like 4, transcript variant X3
follistatin-related protein 4 isoform X2
rap guanine nucleotide exchange factor 6-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
rap guanine nucleotide exchange factor 6-like, transcript variant X2
rap guanine nucleotide exchange factor 6-like, transcript variant X3
rap guanine nucleotide exchange factor 6-like, transcript variant X1
rap guanine nucleotide exchange factor 6-like isoform X7
rap guanine nucleotide exchange factor 6-like isoform X2
rap guanine nucleotide exchange factor 6-like isoform X3
rap guanine nucleotide exchange factor 6-like isoform X1
rap guanine nucleotide exchange factor 6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
rap guanine nucleotide exchange factor 6-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
folliculin-interacting protein 1-like isoform X6
folliculin-interacting protein 1-like isoform X4
rap guanine nucleotide exchange factor 6-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
folliculin-interacting protein 1-like isoform X5
uncharacterized LOC115079873, transcript variant X2
uncharacterized LOC115079873, transcript variant X1
uncharacterized protein LOC115079873 isoform X2
uncharacterized protein LOC115079873 isoform X1
acyl-CoA synthetase long chain family member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon regulatory factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
interferon regulatory factor 1, transcript variant X1
interferon regulatory factor 1 isoform X1
interferon regulatory factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC115079583, transcript variant X1
uncharacterized LOC115079583, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X2
solute carrier family 22 member 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like, transcript variant X3
solute carrier family 22 member 5-like, transcript variant X4
solute carrier family 22 member 5-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
prolyl 4-hydroxylase subunit alpha 2, transcript variant X2
prolyl 4-hydroxylase subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2 isoform X5
prolyl 4-hydroxylase subunit alpha-2 isoform X2
prolyl 4-hydroxylase subunit alpha-2 isoform X1
prolyl 4-hydroxylase subunit alpha 2, transcript variant X4
prolyl 4-hydroxylase subunit alpha-2 isoform X4
prolyl 4-hydroxylase subunit alpha-2 isoform X3
RAD50 double strand break repair protein, transcript variant X1
RAD50 double strand break repair protein, transcript variant X2
kinesin family member 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kinesin family member 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sosondowah ankyrin repeat domain family member A
ankyrin repeat domain-containing protein SOWAHA
shroom family member 1, transcript variant X12
shroom family member 1, transcript variant X5
shroom family member 1, transcript variant X2
shroom family member 1, transcript variant X4
shroom family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
shroom family member 1, transcript variant X1
shroom family member 1, transcript variant X6
shroom family member 1, transcript variant X10
shroom family member 1, transcript variant X11
shroom family member 1, transcript variant X9
shroom family member 1, transcript variant X7
shroom family member 1, transcript variant X8
AF4/FMR2 family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X1
zinc finger CCHC-type containing 10, transcript variant X1
zinc finger CCHC-type containing 10, transcript variant X2
zinc finger CCHC domain-containing protein 10 isoform X1
zinc finger CCHC domain-containing protein 10 isoform X2
heat shock protein family A (Hsp70) member 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ring finger protein 14, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ring finger protein 14, transcript variant X6
ring finger protein 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ring finger protein 14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ring finger protein 14, transcript variant X2
ring finger protein 14, transcript variant X3
E3 ubiquitin-protein ligase RNF14 isoform X1
E3 ubiquitin-protein ligase RNF14 isoform X2
glucosamine-6-phosphate deaminase 1, transcript variant X2
glucosamine-6-phosphate deaminase 1, transcript variant X1
glucosamine-6-phosphate deaminase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucosamine-6-phosphate isomerase 1 isoform X1
glucosamine-6-phosphate isomerase 1 isoform X3
glucosamine-6-phosphate isomerase 1 isoform X2
Nedd4 family interacting protein 1, transcript variant X3
Nedd4 family interacting protein 1, transcript variant X2
Nedd4 family interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X6
Rho GTPase activating protein 26, transcript variant X2
Rho GTPase activating protein 26, transcript variant X3
Rho GTPase activating protein 26, transcript variant X4
Rho GTPase activating protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X5
rho GTPase-activating protein 26 isoform X1
rho GTPase-activating protein 26 isoform X5
rho GTPase-activating protein 26 isoform X2
rho GTPase-activating protein 26 isoform X3
rho GTPase-activating protein 26 isoform X4
Rho GTPase activating protein 26, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho GTPase activating protein 26, transcript variant X8
rho GTPase-activating protein 26 isoform X6
nuclear receptor subfamily 3 group C member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X5
nuclear receptor subfamily 3 group C member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear receptor subfamily 3 group C member 1, transcript variant X7
Yip1 domain family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Yip1 domain family member 5, transcript variant X1
Yip1 domain family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
potassium channel tetramerization domain containing 16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD16
similar to RNA sequence (same species):INSD:GFOG01080000.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 57 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 57 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
glutaredoxin and cysteine rich domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 2
SH3 domain containing ring finger 2, transcript variant X7
SH3 domain containing ring finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SH3 domain containing ring finger 2, transcript variant X2
SH3 domain containing ring finger 2, transcript variant X3
SH3 domain containing ring finger 2, transcript variant X4
E3 ubiquitin-protein ligase SH3RF2 isoform X1
E3 ubiquitin-protein ligase SH3RF2 isoform X2
SH3 domain containing ring finger 2, transcript variant X5
SH3 domain containing ring finger 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SH3 domain containing ring finger 2, transcript variant X6
SH3 domain containing ring finger 2, transcript variant X11
SH3 domain containing ring finger 2, transcript variant X9
SH3 domain containing ring finger 2, transcript variant X8
E3 ubiquitin-protein ligase SH3RF2 isoform X3
leucyl-tRNA synthetase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
leucyl-tRNA synthetase, transcript variant X2
leucine--tRNA ligase, cytoplasmic isoform X1
leucine--tRNA ligase, cytoplasmic isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 4, transcription factor 3
transcription elongation regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription elongation regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase 2 regulatory subunit Bbeta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dihydropyrimidinase-related protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dihydropyrimidinase-related protein 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
janus kinase and microtubule interacting protein 2, transcript variant X1
janus kinase and microtubule interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule-interacting protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dopamine receptor D1, transcript variant X1
dopamine receptor D1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dopamine receptor D1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC115079869, transcript variant X2
uncharacterized LOC115079869, transcript variant X1
neuronal vesicle trafficking associated 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuronal vesicle trafficking associated 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neuronal vesicle trafficking associated 2, transcript variant X5
neuronal vesicle trafficking associated 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuronal vesicle trafficking associated 2, transcript variant X4
neuronal vesicle trafficking associated 2, transcript variant X2
neuronal vesicle trafficking associated 2, transcript variant X13
neuronal vesicle trafficking associated 2, transcript variant X10
neuronal vesicle trafficking associated 2, transcript variant X11
neuronal vesicle trafficking associated 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
neuronal vesicle trafficking associated 2, transcript variant X8
neuronal vesicle trafficking associated 2, transcript variant X7
neuronal vesicle trafficking-associated protein 2 isoform X2
neuronal vesicle trafficking associated 2, transcript variant X14
neuronal vesicle trafficking associated 2, transcript variant X1
neuronal vesicle trafficking-associated protein 2 isoform X3
neuronal vesicle trafficking-associated protein 2 isoform X1
cytoplasmic polyadenylation element binding protein 4
cytoplasmic polyadenylation element-binding protein 4
biorientation of chromosomes in cell division 1, transcript variant X2
biorientation of chromosomes in cell division 1, transcript variant X1
biorientation of chromosomes in cell division protein 1 isoform X1
biorientation of chromosomes in cell division protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BCL2 interacting protein 1, transcript variant X1
BCL2 interacting protein 1, transcript variant X2
vesicle transport protein SEC20 isoform X1
vesicle transport protein SEC20 isoform X2
CREB3 regulatory factor, transcript variant X1
CREB3 regulatory factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal protein L26 like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal protein L26 like 1, transcript variant X2
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X2
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X1
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X3
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X2
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X1
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X3
uncharacterized LOC115079619, transcript variant X2
uncharacterized LOC115079619, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEURL1B isoform X2
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
E3 ubiquitin-protein ligase NEURL1B isoform X1
neuralized E3 ubiquitin protein ligase 1B, transcript variant X3
E3 ubiquitin-protein ligase NEURL1B isoform X3
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X1
serine/threonine kinase 10, transcript variant X1
serine/threonine kinase 10, transcript variant X2
serine/threonine kinase 10, transcript variant X3
serine/threonine kinase 10, transcript variant X4
serine/threonine-protein kinase 10 isoform X2
serine/threonine-protein kinase 10 isoform X1
serine/threonine-protein kinase 10 isoform X3
serine/threonine-protein kinase 10 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
actin binding LIM protein family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X4
actin binding LIM protein family member 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X7
actin binding LIM protein family member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
SH3 domain and tetratricopeptide repeats 2, transcript variant X4
SH3 domain and tetratricopeptide repeats 2, transcript variant X7
SH3 domain and tetratricopeptide repeats 2, transcript variant X6
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
SH3 domain and tetratricopeptide repeats 2, transcript variant X8
SH3 domain and tetratricopeptide repeats 2, transcript variant X5
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X4
actin filament associated protein 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
actin filament-associated protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC115079852, transcript variant X2
uncharacterized LOC115079852, transcript variant X1
uncharacterized LOC115079852, transcript variant X3
uncharacterized LOC115079852, transcript variant X4
uncharacterized LOC115079852, transcript variant X6
uncharacterized LOC115079852, transcript variant X5
uncharacterized LOC115079779, transcript variant X1
uncharacterized LOC115079779, transcript variant X4
uncharacterized LOC115079779, transcript variant X7
uncharacterized LOC115079779, transcript variant X13
uncharacterized LOC115079779, transcript variant X5
uncharacterized LOC115079779, transcript variant X8
uncharacterized LOC115079779, transcript variant X3
uncharacterized LOC115079779, transcript variant X6
uncharacterized LOC115079779, transcript variant X11
uncharacterized LOC115079779, transcript variant X14
uncharacterized LOC115079779, transcript variant X9
uncharacterized LOC115079779, transcript variant X12
uncharacterized LOC115079779, transcript variant X2
uncharacterized LOC115079779, transcript variant X10
uncharacterized LOC115079779, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X3
casein kinase 1 alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: toll-like receptor 13
Rho guanine nucleotide exchange factor 37, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
rho guanine nucleotide exchange factor 37 isoform X1
Rho guanine nucleotide exchange factor 37, transcript variant X2
rho guanine nucleotide exchange factor 37 isoform X2
PPARG coactivator 1 beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PPARG coactivator 1 beta, transcript variant X2
PPARG coactivator 1 beta, transcript variant X1
peroxisome proliferator-activated receptor gamma coactivator 1-beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
sulfate transporter-like, transcript variant X3
sulfate transporter-like, transcript variant X4
sulfate transporter-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sulfate transporter-like, transcript variant X1
5-hydroxytryptamine receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysine-specific demethylase 3B
C-terminal-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
C-terminal-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
oocyte-specific histone RNA stem-loop-binding protein 2-like
GDNF family receptor alpha 3, transcript variant X1
GDNF family receptor alpha 3, transcript variant X2
GDNF family receptor alpha 3, transcript variant X3
cell division cycle 23, transcript variant X2
cell division cycle 23, transcript variant X4
cell division cycle 23, transcript variant X1
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X4
cell division cycle 23, transcript variant X3
cell division cycle protein 23 homolog isoform X2
cell division cycle protein 23 homolog isoform X3
kinesin family member 20A, transcript variant X2
kinesin family member 20A, transcript variant X1
kinesin family member 20A, transcript variant X3
bromodomain containing 8, transcript variant X1
bromodomain containing 8, transcript variant X3
bromodomain containing 8, transcript variant X4
bromodomain containing 8, transcript variant X2
bromodomain containing 8, transcript variant X5
bromodomain-containing protein 8 isoform X1
bromodomain-containing protein 8 isoform X3
bromodomain-containing protein 8 isoform X4
bromodomain-containing protein 8 isoform X2
bromodomain-containing protein 8 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transmembrane emp24 domain-containing protein 9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LOW QUALITY PROTEIN: vesicular integral-membrane protein VIP36
regulator of G protein signaling 14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
regulator of G-protein signaling 14 isoform X2
regulator of G protein signaling 14, transcript variant X1
regulator of G-protein signaling 14 isoform X1
solute carrier family 34 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 34 member 1, transcript variant X2
sodium-dependent phosphate transport protein 2A isoform X2
sodium-dependent phosphate transport protein 2A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GFOG01012842.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; added 120 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; added 120 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: coagulation factor XII
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LOW QUALITY PROTEIN: G protein-coupled receptor kinase 6
ubiquitin interaction motif containing 1, transcript variant X5
ubiquitin interaction motif containing 1, transcript variant X4
ubiquitin interaction motif containing 1, transcript variant X3
ubiquitin interaction motif containing 1, transcript variant X1
ubiquitin interaction motif containing 1, transcript variant X2
BRCA1-A complex subunit RAP80 isoform X3
BRCA1-A complex subunit RAP80 isoform X2
BRCA1-A complex subunit RAP80 isoform X1
BRCA1-A complex subunit RAP80 isoform X4
ubiquitin interaction motif containing 1, transcript variant X10
ubiquitin interaction motif containing 1, transcript variant X11
ubiquitin interaction motif containing 1, transcript variant X8
ubiquitin interaction motif containing 1, transcript variant X7
ubiquitin interaction motif containing 1, transcript variant X6
ubiquitin interaction motif containing 1, transcript variant X9
BRCA1-A complex subunit RAP80 isoform X8
BRCA1-A complex subunit RAP80 isoform X7
BRCA1-A complex subunit RAP80 isoform X6
BRCA1-A complex subunit RAP80 isoform X5
fibroblast growth factor receptor 4, transcript variant X3
fibroblast growth factor receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor receptor 4 isoform X1
fibroblast growth factor receptor 4 isoform X2
nuclear receptor binding SET domain protein 1, transcript variant X3
nuclear receptor binding SET domain protein 1, transcript variant X1
nuclear receptor binding SET domain protein 1, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific
RAB24, member RAS oncogene family, transcript variant X2
RAB24, member RAS oncogene family, transcript variant X1
PRELI domain containing 1, transcript variant X2
PRELI domain containing 1, transcript variant X1
PRELI domain-containing protein 1, mitochondrial isoform X1
PRELI domain-containing protein 1, mitochondrial isoform X2
family with sequence similarity 193 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX41
PDZ and LIM domain protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
PDZ and LIM domain protein 7-like, transcript variant X5
PDZ and LIM domain protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PDZ and LIM domain protein 7-like, transcript variant X1
PDZ and LIM domain protein 7-like, transcript variant X4
PDZ and LIM domain protein 7-like isoform X1
PDZ and LIM domain protein 7-like isoform X2
PDZ and LIM domain protein 7-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
disintegrin and metalloproteinase domain-containing protein 19-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E family member 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 4E type 1B
cadherin related family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cadherin related family member 2, transcript variant X1
cadherin related family member 2, transcript variant X2
cadherin related family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cadherin-related family member 2 isoform X3
cadherin-related family member 2 isoform X1
cadherin-related family member 2 isoform X2
ring finger protein 44, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ring finger protein 44, transcript variant X5
ring finger protein 44, transcript variant X2
ring finger protein 44, transcript variant X1
ring finger protein 44, transcript variant X4
Fas associated factor family member 2, transcript variant X1
Fas associated factor family member 2, transcript variant X2
Fas associated factor family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
clathrin light chain B, transcript variant X1
clathrin light chain B, transcript variant X2
HIG1 hypoxia inducible domain family member 2A
HIG1 domain family member 2A, mitochondrial
KIAA1191 ortholog, transcript variant X1
KIAA1191 ortholog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
putative monooxygenase p33MONOX isoform X1
putative monooxygenase p33MONOX isoform X2
SUMO interacting motifs containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SUMO interacting motifs containing 1, transcript variant X1
SUMO interacting motifs containing 1, transcript variant X3
SUMO-interacting motif-containing protein 1 isoform X1
SUMO-interacting motif-containing protein 1 isoform X2
histamine receptor H2, transcript variant X5
histamine receptor H2, transcript variant X1
histamine receptor H2, transcript variant X2
histamine receptor H2, transcript variant X3
histamine receptor H2, transcript variant X4
histamine receptor H2, transcript variant X6
serine protease inhibitor Kazal-type 1-like
glycine-rich cell wall structural protein 1.8-like
PE-PGRS family protein PE_PGRS33-like, transcript variant X1
PE-PGRS family protein PE_PGRS33-like, transcript variant X2
PE-PGRS family protein PE_PGRS33-like, transcript variant X10
PE-PGRS family protein PE_PGRS33-like, transcript variant X9
PE-PGRS family protein PE_PGRS33-like, transcript variant X8
PE-PGRS family protein PE_PGRS33-like, transcript variant X16
PE-PGRS family protein PE_PGRS33-like, transcript variant X15
PE-PGRS family protein PE_PGRS33-like, transcript variant X7
PE-PGRS family protein PE_PGRS33-like, transcript variant X13
PE-PGRS family protein PE_PGRS33-like, transcript variant X20
PE-PGRS family protein PE_PGRS33-like, transcript variant X17
PE-PGRS family protein PE_PGRS33-like, transcript variant X4
PE-PGRS family protein PE_PGRS33-like, transcript variant X5
PE-PGRS family protein PE_PGRS33-like, transcript variant X6
PE-PGRS family protein PE_PGRS33-like, transcript variant X12
PE-PGRS family protein PE_PGRS33-like, transcript variant X14
PE-PGRS family protein PE_PGRS33-like, transcript variant X19
PE-PGRS family protein PE_PGRS33-like, transcript variant X22
PE-PGRS family protein PE_PGRS33-like, transcript variant X18
PE-PGRS family protein PE_PGRS33-like, transcript variant X24
PE-PGRS family protein PE_PGRS33-like, transcript variant X3
PE-PGRS family protein PE_PGRS33-like, transcript variant X11
PE-PGRS family protein PE_PGRS33-like, transcript variant X26
PE-PGRS family protein PE_PGRS33-like, transcript variant X21
PE-PGRS family protein PE_PGRS33-like, transcript variant X25
PE-PGRS family protein PE_PGRS33-like, transcript variant X23
uncharacterized protein LOC115079838 isoform X1
uncharacterized protein LOC115079838 isoform X2
uncharacterized protein LOC115079838 isoform X10
uncharacterized protein LOC115079838 isoform X9
uncharacterized protein LOC115079838 isoform X8
uncharacterized protein LOC115079838 isoform X16
uncharacterized protein LOC115079838 isoform X15
uncharacterized protein LOC115079838 isoform X7
uncharacterized protein LOC115079838 isoform X13
uncharacterized protein LOC115079838 isoform X20
uncharacterized protein LOC115079838 isoform X17
uncharacterized protein LOC115079838 isoform X4
uncharacterized protein LOC115079838 isoform X5
uncharacterized protein LOC115079838 isoform X6
uncharacterized protein LOC115079838 isoform X12
uncharacterized protein LOC115079838 isoform X14
uncharacterized protein LOC115079838 isoform X19
uncharacterized protein LOC115079838 isoform X22
uncharacterized protein LOC115079838 isoform X18
uncharacterized protein LOC115079838 isoform X24
uncharacterized protein LOC115079838 isoform X3
uncharacterized protein LOC115079838 isoform X11
uncharacterized protein LOC115079838 isoform X26
uncharacterized protein LOC115079838 isoform X21
uncharacterized protein LOC115079838 isoform X25
uncharacterized protein LOC115079838 isoform X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC115079625, transcript variant X2
uncharacterized LOC115079625, transcript variant X1
uncharacterized LOC115079625, transcript variant X3
uncharacterized LOC115079765, transcript variant X1
uncharacterized LOC115079765, transcript variant X2
glycine-rich protein 23-like, transcript variant X1
glycine-rich protein 23-like, transcript variant X2
glycine-rich protein 23-like, transcript variant X3
glycine-rich protein 23-like, transcript variant X4
uncharacterized protein LOC115080083 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: F-box only protein 38